Lin Xie

1.8k total citations
88 papers, 1.4k citations indexed

About

Lin Xie is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Lin Xie has authored 88 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Economics and Econometrics and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Lin Xie's work include Diabetes Management and Research (19 papers), Diabetes Treatment and Management (19 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Lin Xie is often cited by papers focused on Diabetes Management and Research (19 papers), Diabetes Treatment and Management (19 papers) and Health Systems, Economic Evaluations, Quality of Life (9 papers). Lin Xie collaborates with scholars based in United States, China and Türkiye. Lin Xie's co-authors include Onur Başer, Wenhui Wei, Li Wang, Chunshen Pan, Furaha Kariburyo, Hüseyin Yüce, Jincy Paulose, Menaka Bhor, Nirmish Shah and Allison Keshishian and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Lin Xie

83 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin Xie United States	23	374	213	198	180	170	88	1.4k
Suellen M. Curkendall United States	17	284 0.8×	132 0.6×	170 0.9×	184 1.0×	125 0.7×	32	1.5k
Marie‐Hélène Lafeuille United States	23	254 0.7×	67 0.3×	714 3.6×	118 0.7×	220 1.3×	148	2.0k
Michael Eaddy United States	21	77 0.2×	138 0.6×	307 1.6×	217 1.2×	257 1.5×	96	1.5k
Yumin Zhao United States	20	390 1.0×	127 0.6×	100 0.5×	197 1.1×	144 0.8×	39	1.9k
Nikki M. Carroll United States	24	91 0.2×	190 0.9×	170 0.9×	201 1.1×	225 1.3×	60	1.5k
Colette B. Raymond Canada	16	121 0.3×	168 0.8×	90 0.5×	58 0.3×	193 1.1×	65	972
Shravanthi R. Gandra United States	26	161 0.4×	82 0.4×	108 0.5×	79 0.4×	446 2.6×	61	2.1k
Paola Rebora Italy	25	281 0.8×	156 0.7×	90 0.5×	88 0.5×	55 0.3×	122	2.3k
Edward F. Tierney United States	14	567 1.5×	149 0.7×	51 0.3×	71 0.4×	104 0.6×	23	1.4k
Sean McElligott United States	12	245 0.7×	148 0.7×	41 0.2×	51 0.3×	137 0.8×	26	1.0k

Countries citing papers authored by Lin Xie

Since Specialization

Citations

This map shows the geographic impact of Lin Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xie more than expected).

Fields of papers citing papers by Lin Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xie. The network helps show where Lin Xie may publish in the future.

Co-authorship network of co-authors of Lin Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xie. A scholar is included among the top collaborators of Lin Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xie. Lin Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Mei, Min Cui, Xianlin Zeng, et al.. (2025). Letter to the Editor regarding “Global, Regional, and National Burden of Low Back Pain Findings from the Global Burden of Disease Study 2021 and Projections to 2050” by Cheng et al.. Spine. 50(23). E489–E490.

Cheng, Mei, Min Cui, Xianlin Zeng, et al.. (2025). Global, Regional, and National Burden of Low Back Pain. Spine. 50(7). E128–E139. 9 indexed citations

Wang, Yuexi, et al.. (2020). 123. Treatment Patterns and Prevalence of Inappropriate and Suboptimal Antibiotic Use Among Females with Uncomplicated Urinary Tract Infection in the US. Open Forum Infectious Diseases. 7(Supplement_1). S190–S191. 4 indexed citations

Shah, Nirmish, Menaka Bhor, Lin Xie, et al.. (2019). Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based Study. Journal of health economics and outcomes research. 106–117. 2 indexed citations

Keshishian, Allison, Lin Xie, Carole Dembek, & Hüseyin Yüce. (2019). Reduction in Hospital Readmission Rates Among Medicare Beneficiaries With Chronic Obstructive Pulmonary Disease: A Real-world Outcomes Study of Nebulized Bronchodilators. Clinical Therapeutics. 41(11). 2283–2296. 7 indexed citations

Coste, F, Lin Xie, Myrlene Sanon Aigbogun, et al.. (2017). A Real-world Analysis of Treatment Patterns for Cholinesterase Inhibitors and Memantine among Newly-diagnosed Alzheimer’s Disease Patients. Neurology and Therapy. 6(1). 131–144. 22 indexed citations

Brekke, Lee, Erin Buysman, Michael Grabner, et al.. (2017). The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study. Value in Health. 20(10). 1252–1259. 5 indexed citations

Keshishian, Allison, et al.. (2016). Demographic and Socioeconomic Characteristics that Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients. Value in Health. 19(3). A55–A55. 1 indexed citations

Xie, Lin, et al.. (2015). Evaluation of the Burden of Opioid Abuse Among us Veteran Patients. Value in Health. 18(7). A411–A411. 1 indexed citations

10.

Keshishian, Allison, Yuexi Wang, Lin Xie, & Onur Başer. (2015). The economic impact of symptomatic menopause among low-socioeconomic women in the United States. Expert Review of Pharmacoeconomics & Outcomes Research. 16(2). 305–313. 1 indexed citations

11.

Başer, Onur, Arijit Ganguli, Sanjoy Roy, Lin Xie, & Mary Cifaldi. (2015). Impact of Switching From an Initial Tumor Necrosis Factor Inhibitor on Health Care Resource Utilization and Costs Among Patients With Rheumatoid Arthritis. Clinical Therapeutics. 37(7). 1454–1465. 25 indexed citations

12.

Amin, Alpesh, Allison Keshishian, Lin Xie, et al.. (2015). Comparison of Short-Term Bleeding-Related Health Care Utilization and Costs Among Treatment-Naïve Nonvalvular Atrial Fibrillation Patients Initiating Apixaban, Dabigatran, Rivaroxaban, or Warfarin. CHEST Journal. 148(4). 65A–65A. 2 indexed citations

13.

Dasta, Joseph F., Sushrut S. Waikar, Lin Xie, et al.. (2015). Patterns of treatment and correction of hyponatremia in intensive care unit patients. Journal of Critical Care. 30(5). 1072–1079. 9 indexed citations

14.

Xie, Lin, Steve Zhou, Brett Pinsky, Erin Buysman, & Onur Başer. (2014). Impact of Initiating Insulin Glargine Disposable Pen Versus Vial/Syringe on Real-World Glycemic Outcomes and Persistence Among Patients with Type 2 Diabetes Mellitus in a Large Managed Care Plan: A Claims Database Analysis. Diabetes Technology & Therapeutics. 16(9). 567–575. 26 indexed citations

15.

Levin, Philip, Wenhui Wei, Aleksandra Vlajnic, et al.. (2014). Initiating Injectable Therapy in US Managed Care Patients With Diabetes. The American Journal of Managed Care. 6. 1 indexed citations

16.

Xie, Lin, et al.. (2013). Does Pen Help? A Real-World Outcomes Study of Switching from Vial to Disposable Pen Among Insulin Glargine-Treated Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics. 15(3). 230–236. 35 indexed citations

17.

Wang, Li, Wenhui Wei, Raymond Miao, Lin Xie, & Onur Başer. (2013). Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study. BMJ Open. 3(4). e002348–e002348. 35 indexed citations

18.

Başer, Onur, Wenhui Wei, Henry J. Henk, April Teitelbaum, & Lin Xie. (2012). Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry. Current Medical Research and Opinion. 28(3). 419–428. 31 indexed citations

19.

Du, Juan, Wenhui Wei, Lin Xie, Chunshen Pan, & Onur Başer. (2011). PDB25 Real-World Outcomes of Initiating Two Different Basal Insulin Therapies Via Disposable Pens Among Patients with Type 2 Diabetes in US Employer-Sponsored Health Plans. Value in Health. 14(7). A476–A476. 2 indexed citations

20.

Xie, Lin. (2002). Diagnostic Value of Serum Ferritin in Adult Onset Still's Disease. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact